A new publication referencing humanin appeared on July 30, 2026. The paper, titled "AGEs-RAGE Axis and Mitochondrial-Derived Peptides in Advanced Chronic Kidney Disease: Interconnected Pathways Beyond Inflammation and Nutrition," was published in Antioxidants (Basel, Switzerland).
The publication addresses mitochondrial-derived peptides, including humanin, in the context of advanced chronic kidney disease. It discusses these peptides alongside the AGEs-RAGE axis as interconnected pathways described as extending beyond inflammation and nutrition.
Humanin remains classified as an unapproved research compound. No findings, outcomes, or conclusions from this publication are detailed here beyond its title and subject matter. Readers interested in the underlying research should consult the published paper directly through the source link provided.
For additional background on humanin as a compound, readers can consult the compound overview.